MedTrace Logo

Daily Disposable Dispensing Clinical Trial of Test Lens Against Stenfilcon A Lens

NCT03024970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2020-07-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate the overall clinical performance of the test daily disposable stenfilcon A lens with solution additive (test) compared to the stenfilcon A lens (control).

Conditions

  • Myopia

Interventions

DEVICE

stenfilcon A lens with solution additive (test)

silicone hydrogel lens

DEVICE

stenfilcon A lens (control)

contact lens

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Pete Kollbaum, OD, PhD · Clinical Optics Research Lab (CORL) Indiana University School of Optometry.

  • Eric Ritchey, OD, PhD, FAAO · University of Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-04-25
Completion
2017-06-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03024970 on ClinicalTrials.gov